» Authors » Lisa A Kaltenbach

Lisa A Kaltenbach

Explore the profile of Lisa A Kaltenbach including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 61
Citations 953
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Nelson A, Inohara T, Rao S, Kaltenbach L, Wojdyla D, Wang T
Am Heart J . 2022 Oct; 255:117-124. PMID: 36220357
Background: Appropriate use criteria (AUC) have been developed to promote the rational use of percutaneous coronary intervention (PCI) among clinicians and to provide benchmarking feedback to hospitals. The original AUC...
12.
Rao V, Kaltenbach L, Granger B, Fonarow G, Al-Khalidi H, Albert N, et al.
J Card Fail . 2022 Jul; 28(10):1487-1496. PMID: 35905867
Background: It is unknown whether digital applications can improve guideline-directed medical therapy (GDMT) and outcomes in heart failure with reduced ejection fraction (HFrEF). Methods And Results: Care Optimization Through Patient...
13.
Granger B, Kaltenbach L, Fonarow G, Allen L, Lanfear D, Albert N, et al.
J Card Fail . 2022 Apr; 28(8):1355-1361. PMID: 35462033
Background: Health system-level interventions to improve use of guideline-directed medical therapy (GDMT) often fail in the acute care setting. We sought to identify factors associated with high performance in adoption...
14.
Kir D, Zhang S, Kaltenbach L, Fonarow G, Matsouaka R, Piccini J, et al.
Heart Rhythm . 2022 Mar; 19(7):1049-1057. PMID: 35247626
Background: Despite multiple trials comparing rate with rhythm control, there is no consensus on the optimal management of first-detected atrial fibrillation (AF). Objective: We analyzed current patterns of care for...
15.
Nelson A, OBrien E, Kaltenbach L, Green J, Lopes R, Morse C, et al.
JAMA Netw Open . 2022 Feb; 5(2):e2148030. PMID: 35175345
Importance: Based on contemporary estimates in the US, evidence-based therapies for cardiovascular risk reduction are generally underused among patients with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD). Objective: To...
16.
Doll J, Nelson A, Kaltenbach L, Wojdyla D, Waldo S, Rao S, et al.
Circ Cardiovasc Interv . 2021 Dec; 15(1):e010909. PMID: 34847693
Background: Percutaneous coronary intervention is performed by operators with differing experience, technique, and case mix. It is unknown if operator practice patterns impact patient outcomes. We sought to determine if...
17.
Bradley S, Kaltenbach L, Xiang K, Amin A, Hess P, Maddox T, et al.
JACC Cardiovasc Interv . 2021 Aug; 14(15):1655-1666. PMID: 34353597
Objectives: The aims of this study were to describe trends and hospital variation in same-day discharge following elective percutaneous coronary intervention (PCI) and to evaluate the association between trends in...
18.
DeVore A, Granger B, Fonarow G, Al-Khalidi H, Albert N, Lewis E, et al.
JAMA . 2021 Jul; 326(4):314-323. PMID: 34313687
Importance: Adoption of guideline-directed medical therapy for patients with heart failure is variable. Interventions to improve guideline-directed medical therapy have failed to consistently achieve target metrics, and limited data exist...
19.
Nelson A, Pagidipati N, Aroda V, Cavender M, Green J, Lopes R, et al.
Circulation . 2021 Jul; 144(1):74-84. PMID: 34228476
Multiple sodium glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) have been shown to impart significant cardiovascular and kidney benefits, but are underused in clinical practice. Both SGLT-2i...
20.
Manly D, Karrowni W, Rymer J, Kaltenbach L, Swaminathan R, Messenger J, et al.
JACC Cardiovasc Interv . 2021 Apr; 14(8):907-916. PMID: 33812824
Objectives: The aims of this study were to examine rates of radial artery access in post-coronary artery bypass grafting (CABG) patients undergoing diagnostic catherization and/or percutaneous coronary intervention (PCI), whether...